Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNeuroBo Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.45 | -$0.15 | -$0.30 |
| Q2 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
NeuroBo Pharmaceuticals, Inc. Earnings Date And Information
NeuroBo Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.55 earnings per share for the quarter, topping analysts' consensus estimates of $-0.82 by $0.27. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NeuroBo Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-2.46 diluted earnings per share) and currently has a price-to-earnings ratio of 0. NeuroBo Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
NeuroBo Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.82 | -$0.55 | 0.27 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$1.38 | -$1.85 | -0.47 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.95 | -$1.32 | -0.37 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.78 | -$1.05 | -0.27 | $4,000 | |
| 11/13/2023 | Q3 2023 | -$0.11 | -$0.75 | -0.64 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.13 | -$0.15 | -0.02 | $0 | |
| 05/12/2023 | Q1 2023 | -$0.63 | -$0.53 | 0.1 | $0 | |
| 03/30/2023 | Q4 2022 | $1.20 | $0.31 | -0.89 | $0 | |
| 11/14/2022 | Q3 2022 | -$40.88 | -$3.51 | 37.37 | $0 | |
| 08/12/2022 | Q2 2022 | -$40.84 | -$3.72 | 37.12 | $0 | |
| 05/13/2022 | Q1 2022 | -$38.44 | -$3.24 | 35.2 | $0 | |
| 03/31/2022 | Q4 2021 | -$6.16 | $0 | |||
| 11/15/2021 | Q3 2021 | -$43.24 | -$4.66 | 38.58 | $0 | |
| 08/16/2021 | Q2 2021 | -$36.04 | -$5.35 | 30.69 | $0 | |
| 05/17/2021 | Q1 2021 | -$38.44 | -$4.61 | 33.83 | $0 | |
| 04/15/2021 | Q4 2020 | -$35.63 | $0 | |||
| 11/13/2020 | Q3 2020 | -$40.84 | -$5.58 | 35.26 | $0 | |
| 08/11/2020 | Q2 2020 | -$64.86 | -$4.39 | 60.47 | $0 | |
| 05/20/2020 | Q1 2020 | -$3.00 | -$9.06 | -6.06 | $0 | |
| 03/30/2020 | Q4 2019 | -$193.47 | $0 |
NeuroBo Pharmaceuticals, Inc. Earnings: FAQ's
When is NeuroBo Pharmaceuticals, Inc.'s earnings date?
NeuroBo Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
Did NeuroBo Pharmaceuticals, Inc. beat their earnings estimates last
quarter?
In the previous quarter, NeuroBo Pharmaceuticals, Inc. (:NRBO) reported $-0.55 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.82 by $0.27.
How can I listen to NeuroBo Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for NeuroBo Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read NeuroBo Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for NeuroBo Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much profit does NeuroBo Pharmaceuticals, Inc. generate each year?
NeuroBo Pharmaceuticals, Inc. (:NRBO) has a recorded net income of $0. NeuroBo Pharmaceuticals, Inc. has generated $-2.46 earnings per share over the last four quarters.